• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腰围与LMNA相关和不相关的家族性部分脂肪营养不良女性的肝脏脂肪变性和纤维化独立相关。

Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy women.

作者信息

Viola Luiz F, Valerio Cynthia M, Araujo-Neto João M, Santos Fabio F, Matsuura Felipe, Moreira Rodrigo O, Godoy-Matos Amélio F

机构信息

Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione (IEDE), Rua Moncorvo Filho 90, Rio de Janeiro, CEP: 20211-340, Brazil.

Federal University of São Paulo (UNIFESP), São Paulo, Brazil.

出版信息

Diabetol Metab Syndr. 2023 Sep 7;15(1):182. doi: 10.1186/s13098-023-01156-0.

DOI:10.1186/s13098-023-01156-0
PMID:37679847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10483704/
Abstract

BACKGROUND

Lipodystrophies are a heterogeneous group of diseases characterized by the selective loss of subcutaneous adipose tissue and ectopic fat deposition in different organs, including the liver. This study aimed to determine the frequencies of liver steatosis (LS) and liver fibrosis (LF) in a sample of individuals with LMNA-related and unrelated Familial Partial Lipodystrophy.

METHODS

This cross-sectional study included 17 women with LMNA-related FPLD and 15 women with unrelated FPLD. LS and LF were assessed using transient elastography (TE) with FibroScan®. Anthropometric and biochemical variables were included in a multiple linear regression analysis to identify the variables that were independently related to liver disease.

RESULTS

Regarding the presence of LF, 22 (68.2%) women were classified as having non-significant fibrosis, and 10 (31.8%) were classified as having significant or severe fibrosis. Regarding LS, only six women (20.7%) were classified as having an absence of steatosis, and 23 (79.3%) had mild to severe steatosis. After multiple linear regression, waist circumference (but not age, body mass index, or waist-to-hip ratio) was found to be independently related to LS and LF. Among the biochemical variables, only triglyceride levels were independently related to LS but not LF.

CONCLUSIONS

In women with FPLD, visceral fat accumulation appears to be the most important determinant of liver disease, including LF, rather than fat scarcity in the lower limbs.

摘要

背景

脂肪营养不良是一组异质性疾病,其特征为皮下脂肪组织选择性缺失以及不同器官(包括肝脏)出现异位脂肪沉积。本研究旨在确定与LMNA相关和不相关的家族性部分脂肪营养不良个体样本中肝脂肪变性(LS)和肝纤维化(LF)的发生率。

方法

这项横断面研究纳入了17名与LMNA相关的家族性部分脂肪营养不良女性和15名不相关的家族性部分脂肪营养不良女性。使用FibroScan®通过瞬时弹性成像(TE)评估LS和LF。人体测量和生化变量纳入多元线性回归分析,以确定与肝脏疾病独立相关的变量。

结果

关于LF的存在情况,22名(68.2%)女性被归类为无显著纤维化,10名(31.8%)被归类为有显著或严重纤维化。关于LS,只有6名女性(20.7%)被归类为无脂肪变性,23名(79.3%)有轻度至重度脂肪变性。经过多元线性回归分析,发现腰围(而非年龄、体重指数或腰臀比)与LS和LF独立相关。在生化变量中,只有甘油三酯水平与LS独立相关,而与LF无关。

结论

在家族性部分脂肪营养不良女性中,内脏脂肪堆积似乎是包括LF在内的肝脏疾病的最重要决定因素,而非下肢脂肪缺乏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62c/10483704/5fa52c1cbc4b/13098_2023_1156_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62c/10483704/31323a342d86/13098_2023_1156_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62c/10483704/5fa52c1cbc4b/13098_2023_1156_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62c/10483704/31323a342d86/13098_2023_1156_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62c/10483704/5fa52c1cbc4b/13098_2023_1156_Fig2_HTML.jpg

相似文献

1
Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy women.腰围与LMNA相关和不相关的家族性部分脂肪营养不良女性的肝脏脂肪变性和纤维化独立相关。
Diabetol Metab Syndr. 2023 Sep 7;15(1):182. doi: 10.1186/s13098-023-01156-0.
2
Liver steatosis in patients with rheumatoid arthritis treated with methotrexate is associated with body mass index.接受甲氨蝶呤治疗的类风湿关节炎患者的肝脏脂肪变性与体重指数相关。
World J Hepatol. 2023 May 27;15(5):699-706. doi: 10.4254/wjh.v15.i5.699.
3
Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.伴有 LMNA 突变的脂肪营养不良患者的表型多样性。
Eur J Endocrinol. 2012 Sep;167(3):423-31. doi: 10.1530/EJE-12-0268. Epub 2012 Jun 14.
4
The Comparison of Simple Anthropometric and Biochemical Parameters for Predicting Liver Steatosis in Obese Balinese Young Women.用于预测巴厘岛肥胖年轻女性肝脂肪变性的简单人体测量和生化参数比较
Open Access Maced J Med Sci. 2018 Nov 15;6(11):2062-2066. doi: 10.3889/oamjms.2018.449. eCollection 2018 Nov 25.
5
Predicting abdominal adipose tissue among women with familial partial lipodystrophy.预测家族性部分脂肪营养不良女性的腹部脂肪组织。
Metabolism. 2009 Jun;58(6):828-34. doi: 10.1016/j.metabol.2009.03.001.
6
The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011).腿部脂肪与总脂肪比例与非酒精性脂肪性肝病风险降低和肝纤维化程度减轻相关:来自全国性调查(KNHANES 2008-2011)的结果。
Endocrinol Metab (Seoul). 2021 Dec;36(6):1232-1242. doi: 10.3803/EnM.2021.1087. Epub 2021 Nov 23.
7
Hepatic steatosis in Dunnigan-type familial partial lipodystrophy.邓尼根型家族性部分脂肪营养不良中的肝脂肪变性。
Am J Gastroenterol. 2005 Oct;100(10):2218-24. doi: 10.1111/j.1572-0241.2005.00234.x.
8
Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women.人体测量作为女性家族性部分脂肪营养不良的关键诊断工具。
Diabetol Metab Syndr. 2024 Sep 4;16(1):216. doi: 10.1186/s13098-024-01413-w.
9
Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety.家族性部分脂肪营养不良(邓尼根型)中糖尿病的危险因素。
Diabetes Care. 2003 May;26(5):1350-5. doi: 10.2337/diacare.26.5.1350.
10
Evaluation of epicardial adipose tissue in familial partial lipodystrophy.家族性部分脂肪营养不良中心外膜脂肪组织的评估
Diabetol Metab Syndr. 2015 Apr 1;7:29. doi: 10.1186/s13098-015-0024-5. eCollection 2015.

引用本文的文献

1
Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy.巴西关于家族性部分脂肪营养不良的诊断、分类、并发症筛查及治疗的专家共识。
Diabetol Metab Syndr. 2025 Jun 2;17(1):186. doi: 10.1186/s13098-025-01733-5.

本文引用的文献

1
Molecular and Cellular Bases of Lipodystrophy Syndromes.脂肪营养不良综合征的分子和细胞基础。
Front Endocrinol (Lausanne). 2022 Jan 3;12:803189. doi: 10.3389/fendo.2021.803189. eCollection 2021.
2
Relationship Between Lipodystrophy, Body Composition, Metabolic Profile, and Serum Levels of Adipocytokines.脂肪营养不良、身体成分、代谢状况与脂肪细胞因子血清水平之间的关系
Front Nutr. 2021 Dec 9;8:750721. doi: 10.3389/fnut.2021.750721. eCollection 2021.
3
The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes.
成年人 1 型糖尿病中非酒精性脂肪肝与体脂分布的关系。
Diabetes Care. 2021 Jul;44(7):1706-1713. doi: 10.2337/dc20-3175. Epub 2021 May 24.
4
Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease.成像技术在非酒精性脂肪性肝病诊断和分期中的非侵入性评估应用。
Metabolism. 2020 Nov;112:154355. doi: 10.1016/j.metabol.2020.154355. Epub 2020 Sep 9.
5
Established and emerging factors affecting the progression of nonalcoholic fatty liver disease.影响非酒精性脂肪性肝病进展的既存和新兴因素。
Metabolism. 2020 Oct;111S:154183. doi: 10.1016/j.metabol.2020.154183. Epub 2020 Feb 14.
6
Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.脂肪性肝病与脂肪营养不良:综述及对脂联素和/或瘦素替代治疗的展望。
Metabolism. 2019 Jul;96:66-82. doi: 10.1016/j.metabol.2019.05.001. Epub 2019 May 6.
7
Visceral fat does not contribute to metabolic disease in lipodystrophy.内脏脂肪对脂肪营养不良中的代谢疾病没有影响。
Obes Sci Pract. 2019 Jan 24;5(1):75-82. doi: 10.1002/osp4.319. eCollection 2019 Feb.
8
Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.家族性部分性脂肪营养不良患者的临床表现、代谢异常及终末器官并发症
Metabolism. 2017 Jul;72:109-119. doi: 10.1016/j.metabol.2017.04.010. Epub 2017 Apr 27.
9
Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort.与部分脂肪营养不良相关的疾病谱:来自一个试验队列的经验教训
Clin Endocrinol (Oxf). 2017 May;86(5):698-707. doi: 10.1111/cen.13311. Epub 2017 Mar 27.
10
Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.整合基因组分析表明,外周脂肪储存能力有限与人类胰岛素抵抗的发病机制有关。
Nat Genet. 2017 Jan;49(1):17-26. doi: 10.1038/ng.3714. Epub 2016 Nov 14.